Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generics, Bulk Business Get Additional Attention From Wholesalers

Executive Summary

The "big three" wholesalers are looking to additional avenues for increasing profitability in their pharmaceutical distribution business following the adoption of fee-for-service agreements with brand manufacturers
Advertisement

Related Content

Wal-Mart Discount Drug Program Casts Shadow Over Generic Supply Chain
Wal-Mart Discount Drug Program Casts Shadow Over Generic Supply Chain
Wholesalers Beginning To Maximize Value Of Fee-For-Service Deals
Wholesalers Beginning To Maximize Value Of Fee-For-Service Deals
Wholesalers Beginning To Maximize Value Of Fee-For-Service Deals
Cardinal “Fee-For-Service” Model Includes Rx Product Integrity Payments
Advertisement
UsernamePublicRestriction

Register

PS047470

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel